Legal Representation
Attorney
Lori Sandman
USPTO Deadlines
Next Deadline
1904 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250311)
Due Date
March 11, 2031
Grace Period Ends
September 11, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 11, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 11, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 21, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 11, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 11, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 11, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 11, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Dec 11, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Dec 11, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Sep 3, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 3, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 3, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 29, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 30, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research, namely, conducting clinical trials for others
First Use Anywhere:
Sep 2, 2022
First Use in Commerce:
Sep 2, 2022
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICAL TRIALS"